PRME
Prime Medicine Inc

2,652
Mkt Cap
$727.46M
Volume
2.85M
52W High
$6.94
52W Low
$1.11
PE Ratio
-2.81
PRME Fundamentals
Price
$4.15
Prev Close
$4.03
Open
$4.00
50D MA
$3.87
Beta
2.14
Avg. Volume
3.81M
EPS (Annual)
-$1.65
P/B
4.62
Rev/Employee
$13,939.25
Loading...
Loading...
News
all
press releases
Prime Medicine (NYSE:PRME) Trading Down 5.5% - What's Next?
Prime Medicine (NYSE:PRME) Trading Down 5.5% - What's Next...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Prime Medicine (NASDAQ:PRME) Shares Down 5.6% - What's Next?
Prime Medicine (NASDAQ:PRME) Trading Down 5.6% - Here's Why...
MarketBeat·3d ago
News Placeholder
Prime Medicine (NASDAQ:PRME) Shares Up 10.5% - Here's Why
Prime Medicine (NASDAQ:PRME) Trading 10.5% Higher - Here's Why...
MarketBeat·7d ago
News Placeholder
Prime Medicine (NYSE:PRME) Shares Up 12.4% - Time to Buy?
Prime Medicine (NYSE:PRME) Stock Price Up 12.4% - Here's Why...
MarketBeat·7d ago
News Placeholder
Sumitomo Mitsui Trust Group Inc. Boosts Stake in Prime Medicine, Inc. $PRME
Sumitomo Mitsui Trust Group Inc. boosted its holdings in Prime Medicine, Inc. (NYSE:PRME - Free Report) by 127.7% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The...
MarketBeat·12d ago
News Placeholder
Prime Medicine (NASDAQ:PRME) Trading Down 7.9% - Should You Sell?
Prime Medicine (NASDAQ:PRME) Trading Down 7.9% - What's Next...
MarketBeat·14d ago
News Placeholder
Prime Medicine (NYSE:PRME) Trading Down 5.7% - What's Next?
Prime Medicine (NYSE:PRME) Shares Down 5.7% - Here's What Happened...
MarketBeat·14d ago
News Placeholder
Prime Medicine, Inc. (NYSE:PRME) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Prime Medicine, Inc. (NYSE:PRME - Get Free Report) has received an average rating of "Moderate Buy" from the seven research firms that are covering the firm, MarketBeat Ratings reports. Three...
MarketBeat·15d ago
News Placeholder
Prime Medicine (NYSE:PRME) Stock Price Up 7.3% - Here's Why
Prime Medicine (NYSE:PRME) Shares Up 7.3% - Still a Buy...
MarketBeat·15d ago
News Placeholder
Prime Medicine (NASDAQ:PRME) Shares Up 8.4% - Should You Buy?
Prime Medicine (NASDAQ:PRME) Shares Up 8.4% - What's Next...
MarketBeat·15d ago
<
1
2
...
>

Latest PRME News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.